Aseries of adamantane derivatives incorporating amino-acid residues have been synthesized for the first time and their antiviral activity with respect to influenza Avirus subtypes A(H1N1)v and A(H3N2) has been studied. It is established that some of the synthesized compounds can inhibit influenza A virus strains resistant to rimantadine. Thus, restoration of the antiviral activity of rimantadine with respect to resistant influenza strains is possible.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
K. N. Kozeletskaya, L. L. Stotskaya, A. V. Serbii, et al., Vopr. Virusol., 48(5), 19–25 (2003).
D. K. L’vov, E. I. Burtseva, and A. G. Prilipov, Vopr. Virusol., 54(5), 10–14 (2009).
E. I. Burtseva, E. S. Shevchenko, and I. A. Leneva, Vopr. Virusol., 52(2), 24–29 (2007).
I. A. Leneva, N. I. Fadeeva, and I. T. Fedyakina, Khim.-farm. Zh., 28(9), 4–15 (1994).
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 46, No. 1, pp. 3 – 7, January, 2012.
Rights and permissions
About this article
Cite this article
Shibnev, V.A., Garaev, T.M., Finogenova, M.P. et al. Some pathways to overcoming drug resistance of influenza a virus to adamantane derivatives. Pharm Chem J 46, 1–5 (2012). https://doi.org/10.1007/s11094-012-0723-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-012-0723-2